FDA Approves Gardasil as First Anal Cancer Vaccine

POZ: "Though anal cancer is relatively rare in the general population, rates are far higher in men who have sex with men (MSM), and it’s nearly 60 times more common in HIV-positive MSM. For this reason, providers who treat people with HIV have been eager to see the vaccine approved for this purpose."